Rising Pharmaceuticals Inc., a generic pharma firm, has moved into a new headquarters in Saddle Brook after an ongoing period of growth, according to real estate services firm Cushman & Wakefield.
The company signed for 37,000 square feet at Park 80 West, a Class A property at 250 Pehle Ave., moving from Allendale after a period of growth. Its marketing and distribution departments have already made the move, according to the release.
C&W’s Ben Brenner represented the company in its site search and long-term lease, along with Todd Elfand.
“Rising Pharmaceuticals wanted to capitalize on its growth and lease expiration to leverage it as an opportunity to establish a modern, contemporary work environment for its employees,” Brenner said in a prepared statement. “After a multimarket site search, Park 80 West became the clear favorite. The ownership, CBRE, recently completed an $11 million capital improvement program of the asset, which included substantial amenity upgrades.”
Rising is the finished dosage form generics unit of ACETO Corp., an international health products business.
“Rising Pharmaceuticals is a world-class organization, and we were honored to represent the firm in its renewed commitment to doing business in the state of New Jersey,” Brenner said.
